Topic Paragraphs
Call-To-Action Title
FDA to Discuss COVID-19 Vaccine Boosters
Call-To-Action Title
FDA to Discuss COVID-19 Vaccine Boosters
October 20, 2021 at 6:15 pm ET – FDA leaders discuss FDA's authorization of booster doses for eligible populations of Moderna COVID-19 Vaccine and Pfizer-BioNTech COVID-19 Vaccine recipients and Janssen COVID-19 Vaccine recipients 18 and older, as well as the FDA's authorization of the use of heterologous ("mix and match") boosters.
Listen to Media Call
Featured Topics
New Era of Smarter Food Safety
A new approach to food safety that recognizes and builds on the progress made in the past but looks towards what processes and tools will be needed for the future.
Fostering Drug Competition
Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.
Combating the Opioid Crisis
FDA takes actions to combat prescription opioid abuse.
Recalls, Market Withdrawals, & Safety Alerts
The FDA provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this website
Oct 21
Smilin’ Bob’s Issues Allergy Alert On Undeclared Egg In Smilin’ Bob’s Smoked Fish Dip Products
Food & Beverages
Oct 20
Prosource Produce LLC Voluntarily Recalls Whole Raw Onions Shipped From Chihuahua, Mexico, Between July 1, 2021, and August 31, 2021, Because of Possible Health Risk
Food & Beverages
Oct 19
Ivar's Soup and Sauce Company Recalls Kettle Classic Clam Chowder with Uncured Bacon Because the Product may Contain Hard Plastic Pieces
Food & Beverages
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
How CDRH’s Digital Transformation Initiative Will Strengthen the Premarket Review Program
To meet our public health mission, it is critical that FDA continues to evolve to help speed innovations that make medical products safer and more effective.
FDA’s Advanced Manufacturing Initiatives Helping to Provide Quality Human Drugs for Patients
FDA has established numerous initiatives, including the development of a research program to better understand the science of advanced manufacturing.
Advancing the Development of Innovative Veterinary Products
FDA takes a proactive approach to provide timely and efficient review of innovative medical products for animals.
Recently Published Guidances
Oct 21
Data Standards for Drug and Biological Product Submissions Containing Real-World Data
Biologics, Drugs
Oct 20
Regulatory Requirements for Hearing Aid Devices and Personal Sound Amplification Products
Medical Devices
Oct 20
Guidance for Industry: Preparation of Food Contact Substance Notifications (Toxicology Recommendations)
Food & Beverages